Skip to content
    Font Size

    5 Genes Linked to Aggressive Prostate Cancer

    Study Could Lead to Test That Determines Which Patients Need Aggressive Treatment
    WebMD Health News
    Reviewed by Laura J. Martin, MD

    Aug. 16, 2011 -- Researchers in Seattle and Sweden have identified five inherited genetic markers that could help spot men with the most aggressive and deadly forms of prostate cancer.

    They say the discovery may lead to a simple blood test to help distinguish between men with prostate cancer who need aggressive treatment and those who don't.

    Overtreatment is a major concern in prostate cancer in part because the most widely used therapies -- surgery and radiation -- can cause lifelong side effects including impotence and incontinence.

    Genetic markers that can distinguish between patients with aggressive and non-aggressive prostate cancers are urgently needed, Janet L. Stanford, PhD, of the Fred Hutchinson Cancer Center tells WebMD.

    She adds that the markers identified by her research team represent the first evidence that gene variants known as single-nucleotide polymorphisms (SNPs) play a role in prostate cancer progression.

    Identifying High-Risk Patients

    SNPs are single-letter variations within the four-letter DNA alphabet. They are increasingly recognized as having an important role in disease progression.

    "Ultimately, these markers could be used in the clinic, along with other known predictors that are used to assess tumor aggressiveness, such as a high Gleason score, to identify men with a high-risk profile," Stanford says in a news release.

    About 200,000 prostate cancers are diagnosed each year in the U.S. About 30,000 men die of the disease.

    Often prostate cancer is slow growing. Men with the disease often die of other causes before the malignancy turns deadly.

    But prostate cancer patients are usually treated with either surgery or radiation because there is no reliable way to determine if an individual patient's prostate cancer is slow growing or aggressive, William Phelps, PhD, of the American Cancer Society tells WebMD.

    In the newly published study, Stanford and colleagues analyzed DNA samples from 1,309 Seattle-based prostate cancer patients, looking for gene variants suspected of being involved in tumor progression.

    The analysis of 156 candidate genes identified 22 SNPs linked to prostate cancer-specific death.

    In a separate analysis, the researchers examined these variants in stored DNA samples from close to 2,900 prostate cancer patients in Sweden who had been followed for an average of six and a half years.

    Today on WebMD

    man with doctor
    Symptoms, risks, treatments
    man coughing
    Men shouldn’t ignore
    prostate cancer cells
    What does this diagnosis mean?
    doctor and male patient
    Is it worth it?
    cancer fighting foods
    15 Cancer Symptoms Men Ignore
    Prostate Enlarged
    Picture Of The Prostate
    Prostate Cancer Quiz
    screening tests for men
    Prostate Cancer Symptoms
    Vitamin D